These results indicate that the inhibitory effects of Trim44 KO on ISO-induced pathological myocardial hypertrophy were achieved, at least in part, through inhibition of the AKT/mTOR signaling pathway. This evidence concerns the gene AKT1 and cardiac hypertrophy.